• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Quality of Life Measurement in Neurodegenerative and Related Conditions

Quality of Life Measurement in Neurodegenerative and Related Conditions

9780521829014
277.14 zł
249.42 zł Save 27.72 zł Tax included
Lowest price within 30 days before promotion: 249.42 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Patient reported outcome measures are central to the evaluation of medical care and treatment regimes. Such measures depart from traditional clinical assessments as they are based on issues known to be of importance to patients. This book outlines the development and application of a variety of such measures in a wide range of neurological conditions. Introductory chapters outline issues in the application and validation of quality-of-life measures in neurology. Subsequent chapters survey the most widely used quality-of-life instruments in Parkinsons disease, motor neurone disease, multiple sclerosis, multiple system atrophy, progressive supranuclear palsy, and Alzheimers/dementia. A chapter on cerebral palsy deals with the particular challenges to developing outcome measures for children. The book also addresses issues relating to the translation of measures for use in cross-cultural studies, handling missing data, carer experiences of long-term conditions, and methodological challenges. Essential reading for clinicians and researchers working in the field of neurology.
Product Details
66477
9780521829014
9780521829014

Data sheet

Publication date
2011
Issue number
1
Cover
hard cover
Pages count
206
Dimensions (mm)
194.00 x 252.00
Weight (g)
620
  • Preface; 1. Health status measures in neurodegenerative disorders Crispin Jenkinson, Robert Harris and Mark Bromberg; 2. Criteria for assessing health status measures Ray Fitzpatrick and Crispin Jenkinson; 3. Parkinsons disease Crispin Jenkinson and Ray Fitzpatrick; 4. Motor neurone disease Crispin Jenkinson, Ray Fitzpatrick, Robert Harris and Mark Bromberg; 5. Multiple sclerosis Jeremy Hobart; 6. Multiple system atrophy Anette Schrag, Caroline Selai and Robert Harris; 7. Progressive supranuclear palsy Anette Schrag, Caroline Selai and Robert Harris; 8. Alzheimers/dementia Elizabeth Gibbons and Michele Peters; 9. Cerebral palsy Elizabeth Waters, Amy Shelly and Elise Davis; 10. Individualised measures of quality of life Mark Bromberg; 11. Rasch analysis of health status data Jeremy Hobart; 12. Carers and neurodegenerative disease Michele Peters, Ray Fitzpatrick and Crispin Jenkinson; 13. Missing data in trials Crispin Jenkinson, Robert Harris and Ray Fitzpatrick; 14. Issues in the cross cultural adaptation of quality of life measures Michele Peters; Glossary; Index.
Comments (0)